Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01351103
Title A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals

head and neck cancer

cervical squamous cell carcinoma

head and neck squamous cell carcinoma

triple-receptor negative breast cancer

pancreatic cancer

lung squamous cell carcinoma

esophagus squamous cell carcinoma


colorectal cancer

pancreatic adenocarcinoma

Advanced Solid Tumor



LGK974 + Spartalizumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

Additional content available in CKB BOOST